The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β

We identified marmoset as the only non-human primate species that carries Glu 64 in its IL-1b and demonstrates full cross-reactivity of canakinumab, thereby enabling toxicological studies in this species

Jean-Michel Rondeau; Paul Ramage; Mauro Zurini; Hermann Gram


Scholarcy highlights

  • Human IL-1b is a highly regulated, highly active pro-inflammatory cytokine that plays a key role in autoinflammatory and autoimmune diseases. IL-1b signaling requires the sequential assembly of a heterotrimeric complex comprising IL-1b and 2 transmembrane receptors, the type I IL-1 receptor and the IL-1 receptor accessory protein
  • Overall structure of the canakinumab Fab The crystalstructure of the free canakinumab Fab was determined to 2.0 A resolution from a monoclinic crystal with 4 Fab molecules in the asymmetric unit
  • The crystal structures of the canakinumab Fab in the free and IL-1b-bound states reported here were determined from crystal forms that were distinct from those recently reported
  • Human dermal fibroblasts were stimulated with recombinant human IL-1b or cell derived marmoset IL-1b in the presence of canakinumab or recombinant human IL-1 receptor antagonist
  • The structural overlay presented here proves that the canakinumab VH-VL domain binds its antigen essentially as a rigid body, which is typical of affinity-matured antibodies
  • Regarding the mechanism of action, our results indicate that canakinumab inhibits the first step in the assembly of the IL-1 receptor ternary complex, the association of IL-1b with IL-1RI
  • 360 images of 0.5 oscillation each were recorded at a crystal-to-detector distance of 200 mm, and processed with HKL2000.29 The structure was determined by molecular replacement with the program Phaser, using PDB entry 2I1B for human IL-1b4 and the structure of the free canakinumab Fab. Initial refinement was performed with the programs CNX27 and O28 as before

Need more features? Save interactive summary cards to your Scholarcy Library.